Literature DB >> 3971800

The long-term results of excisional surgery for primary and recurrent Crohn's disease of the large intestine.

J C Goligher.   

Abstract

Two-hundred and seven survivors of excisional surgery for primary Crohn's disease of the large intestine have been followed for a mean period of 15 years (range, 7 to 25 years). Of the 45 patients who were treated by colectomy and ileorectal anastomosis, 32 (71 percent) developed recurrence in the terminal ileum, rectum, or ileum and rectum, (and in the duodenum in one). Most recurrences appeared during the first few years, but there appeared to be some continuing predisposition to recurrence indefinitely. Nineteen of the patients with recurrences proceeded to rectal excision and ileostomy. A total of 17 patients (3 percent) with or without recurrence had good functional results with a retained ileorectal anastomosis. Of the 162 patients who were treated by ileostomy and colectomy or proctocolectomy (rarely rectal excision and iliac colostomy), 24 (14.8 percent) had recurrences, usually in the bowel immediately above the stoma and, occasionally, more extensively elsewhere. Most recurrences manifested themselves in the first eight to ten years after operation, and the continuing predisposition thereafter was relatively slight. The inconvenience occasioned by the stoma in these 162 patients was rated as nil in 36.4 percent, negligible in 33.3 percent, moderate or severe in 25.3 percent, and ileostomy refashioning was performed in 5.0 percent with improvement in most instances. The overall condition of the 162 patients was considered to be excellent in 71 percent, fair in 22.8 percent, and poor in 6.2 percent.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1985        PMID: 3971800     DOI: 10.1007/bf02553908

Source DB:  PubMed          Journal:  Dis Colon Rectum        ISSN: 0012-3706            Impact factor:   4.585


  14 in total

1.  Post-operative recurrence of Crohn's disease after definitive stoma: an underestimated risk.

Authors:  Dine Koriche; Corinne Gower-Rousseau; Charbel Chater; Alain Duhamel; Julia Salleron; Noémie Tavernier; Jean-Frédéric Colombel; Benjamin Pariente; Antoine Cortot; Philippe Zerbib
Journal:  Int J Colorectal Dis       Date:  2016-11-24       Impact factor: 2.571

Review 2.  Systematic review with meta-analysis: recurrence of Crohn's disease after total colectomy with permanent ileostomy.

Authors:  M Fumery; P S Dulai; P Meirick; A M Farrell; S Ramamoorthy; W J Sandborn; S Singh
Journal:  Aliment Pharmacol Ther       Date:  2016-12-08       Impact factor: 8.171

3.  The results of surgery for large bowel Crohn's disease.

Authors:  J K Ritchie
Journal:  Ann R Coll Surg Engl       Date:  1990-05       Impact factor: 1.891

Review 4.  Medical or surgical treatment for Crohn's disease?

Authors:  R N Allan
Journal:  Postgrad Med J       Date:  1988-10       Impact factor: 2.401

5.  Surgical treatment of Crohn's disease affecting mainly or entirely the large bowel.

Authors:  J C Goligher
Journal:  World J Surg       Date:  1988-04       Impact factor: 3.352

Review 6.  Surgical treatment of inflammatory bowel disease--a review of some current opinions and controversies.

Authors:  G Ekelund; T Lindhagen; C Lindström; J Stewénius
Journal:  Jpn J Surg       Date:  1987-11

Review 7.  Colonic crohn disease.

Authors:  Traci L Hedrick; Charles M Friel
Journal:  Clin Colon Rectal Surg       Date:  2013-06

8.  Postoperative outcome of Crohn's disease in 30 children.

Authors:  M Besnard; O Jaby; J F Mougenot; L Ferkdadji; A Debrun; C Faure; P Delagausie; M Peuchmaur; Y Aigrain; J Navarro; J P Cézard
Journal:  Gut       Date:  1998-11       Impact factor: 23.059

9.  The surgical options and management of intestinal Crohn's disease.

Authors:  Raaj Chandra; James W E Moore
Journal:  Indian J Surg       Date:  2011-09-08       Impact factor: 0.656

10.  Crohn's disease: risk of recurrence and reoperation in a defined population.

Authors:  S Shivananda; M L Hordijk; A S Pena; J F Mayberry
Journal:  Gut       Date:  1989-07       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.